Open AccessTargeted Therapies for AML
Author(s) -
Farhad Ravandi
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000534130.10647.06
Subject(s) - midostaurin , medicine , myeloid leukemia , oncology , idh1 , idh2 , targeted therapy , isocitrate dehydrogenase , drug development , cancer research , pharmacology , drug , biology , cancer , gene , mutation , genetics , enzyme , biochemistry